Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boundless Bio Inc (BOLD)

Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Boundless Bio Inc 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121 USA

https://boundlessbio.com Employees: 64 P: 858-766-9912

Sector:

Medical

Description:

Boundless Bio Inc. is a clinical stage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers. Boundless Bio Inc. is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 27,535
Enterprise Value, $K 945
Shares Outstanding, K 22,386
Float, K 17,663
% Float 78.90%
Short Interest, K 65
Short Float 0.29%
Days to Cover 1.00
Short Volume Ratio 0.23
% of Insider Shareholders 21.10%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -65,360 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -13,880 K
EBIT, $ -67,830 K
EBITDA, $ -66,740 K

Growth:

1-Year Return -51.75%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.62 on 11/05/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -2.77
EPS Growth vs. Prev Qtr 11.43%
EPS Growth vs. Prev Year 16.22%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BOLD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -47.50%
Return-on-Assets % -33.12%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.25
Book Value/Share 4.92
Interest Coverage -2.63
60-Month Beta -0.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar